In this episode I speak to Tim Baker, a familiar face in the community with a long and storied history in various data and markets roles.

In our conversation of two halves, Tim and I start by discussing a court case in which Tim is taking a deep interest, around the fate of the CUSIP identifier. We then discuss Tim’s recent coup in which he swooped to buy the assets of the IEX Cloud platform from his former employer, we discuss what he now plans to do with it.

DISCLAIMER

This podcast is an edited recording of an interview with Tim Baker recorded in September 2024. The views and opinions expressed in this interview are those of Tim Baker and Mark Fleming-Williams and do not necessarily reflect the official policy or position of either CFM or any of its affiliates. The information provided herein is general information only and does not constitute investment or other advice. Any statements regarding market events, future events or other similar statements constitute only subjective views, are based upon expectations or beliefs, involve inherent risks and uncertainties and should therefore not be relied on. Future evidence and actual results could differ materially from those set forth, contemplated by or underlying these statements. In light of these risks and uncertainties, there can be no assurance that these statements are or will prove to be accurate or complete in any way.

Hosted on Acast. See acast.com/privacy for more information.

In this episode I speak to Brian Peltonen, longtime Director of Data Analytics at Fidelity and recent co-founder of his new startup, Parcosm.

In our conversation, Brian and I talk about his development from computer game programmer to alternative data guru, and how the types of data that is available have changed over the years, as pricing trends and achievable alpha have also shifted.

We also discuss the vision for Parcosm.

DISCLAIMER

This podcast is an edited recording of an interview with Brian Peltonen recorded in August 2024. The views and opinions expressed in this interview are those of Brian Peltonen and Mark Fleming-Williams and do not necessarily reflect the official policy or position of either CFM or any of its affiliates. The information provided herein is general information only and does not constitute investment or other advice. Any statements regarding market events, future events or other similar statements constitute only subjective views, are based upon expectations or beliefs, involve inherent risks and uncertainties and should therefore not be relied on. Future evidence and actual results could differ materially from those set forth, contemplated by or underlying these statements. In light of these risks and uncertainties, there can be no assurance that these statements are or will prove to be accurate or complete in any way.

Hosted on Acast. See acast.com/privacy for more information.

Welcome to the Alternative Data Podcast, powered by CFM. I’m Mark Fleming-Williams.

In this episode I speak to Mathias Dail, Co-founder and CEO at Exorde a data provider that ‘tells you what the world thinks in real time’.

In our conversation, we talk about the benefits of starting a company in Lyon, and Mathias’s achievements in building out his vision for a crowd-sourced exhaustive social media dataset that is perfectly point in time thanks to blockchain technology.

One mistake correction – in the episode when I talk about pigeons, I actually mean sparrows.

DISCLAIMER

This podcast is an edited recording of an interview with Mathias Dail recorded in July 2024. The views and opinions expressed in this interview are those of Mathias Dail and Mark Fleming-Williams and do not necessarily reflect the official policy or position of either CFM or any of its affiliates. The information provided herein is general information only and does not constitute investment or other advice. Any statements regarding market events, future events or other similar statements constitute only subjective views, are based upon expectations or beliefs, involve inherent risks and uncertainties and should therefore not be relied on. Future evidence and actual results could differ materially from those set forth, contemplated by or underlying these statements. In light of these risks and uncertainties, there can be no assurance that these statements are or will prove to be accurate or complete in any way.

Hosted on Acast. See acast.com/privacy for more information.